The current financial score of Milestone Scientific Inc is 7.28. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 2.84M, representing a year-over-year increase of 22.28%, while its net profit experienced a year-over-year increase of 28.57%.
The current valuation score of Milestone Scientific Inc is 8.51. Its current P/E ratio is -7.53, which is -60.17% below the recent high of -3.00 and -198.98% above the recent low of -22.52.
The current earnings forecast score of Milestone Scientific Inc is 8.00. The average price target is 1.25, with a high of 1.50 and a low of 1.00.
The current price momentum score of Milestone Scientific Inc is 4.88. Currently, the stock price is trading between the resistance level at 0.51 and the support level at 0.36, making it suitable for range-bound swing trading.
The current institutional shareholding score of Milestone Scientific Inc is 3.00. The latest institutional shareholding proportion is 7.81%, representing a quarter-over-quarter increase of 37.02%. The largest institutional shareholder is James Simons, holding a total of 56.30K shares, representing 0.00% of shares outstanding, with 77.27% decrease in holdings.
The current risk assessment score of Milestone Scientific Inc is 2.38. The company's beta value is 1.04. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.